当前位置:首页 - 行情中心 - 泓博医药(301230) - 财务分析

泓博医药

(301230)

  

流通市值:20.73亿  总市值:37.58亿
流通股本:5937.17万   总股本:1.08亿

泓博医药(301230)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.04亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益110335.36万元,未分配利润18996.31万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产145093.89万元,负债34758.53万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入130,725,745.26489,717,074.89367,212,523.37237,655,059.97
营业总成本135,325,810.41450,092,838.01319,387,817.06200,328,331.16
营业利润1,764,717.0237,444,320.6249,494,909.7536,771,258.41
利润总额1,857,877.536,762,779.7748,999,641.3336,498,427.86
净利润3,667,660.5637,619,249.0945,934,017.7232,888,192.76
其他综合收益-82,460.8669,910.2682,460.86
综合收益总额3,667,660.5637,701,709.9546,003,927.9832,970,653.62
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计701,273,371.03731,324,912.6775,266,232.76865,449,388.67
非流动资产合计749,665,569.24755,839,010.17707,930,051.68502,747,340.45
资产总计1,450,938,940.271,487,163,922.771,483,196,284.441,368,196,729.12
流动负债合计176,874,745.31191,221,749.06167,271,471.42109,246,378.87
非流动负债合计170,710,574.99178,397,507.18190,077,928.46146,136,740.05
负债合计347,585,320.3369,619,256.24357,349,399.88255,383,118.92
归属于母公司股东权益合计1,103,353,619.971,117,544,666.531,125,846,884.561,112,813,610.2
股东权益合计1,103,353,619.971,117,544,666.531,125,846,884.561,112,813,610.2
负债和股东权益合计1,450,938,940.271,487,163,922.771,483,196,284.441,368,196,729.12
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计133,017,248.48500,445,249.2387,471,981.49271,799,726.6
经营活动现金流出小计123,741,399.65479,586,851.22334,749,104.42235,698,018.29
经营活动产生的现金流量净额9,275,848.8320,858,397.9852,722,877.0736,101,708.31
投资活动现金流入小计148,976,301.521,187,991,463.411,000,689,006.94636,873,155.93
投资活动现金流出小计218,894,430.751,770,269,379.011,658,082,653.351,251,835,483.11
投资活动产生的现金流量净额-69,918,129.23-582,277,915.6-657,393,646.41-614,962,327.18
筹资活动现金流入小计7,337,919.4915,909,684.1410,165,284.4910,000,000
筹资活动现金流出小计22,139,116.0572,099,979.3153,878,595.0946,631,823.34
筹资活动产生的现金流量净额-14,801,196.56-56,190,295.17-43,713,310.6-36,631,823.34
汇率变动对现金及现金等价物的影响1,231,484.31-535,567.711,068,120.86785,938.34
现金及现金等价物净增加额-74,211,992.65-618,145,380.5-647,315,959.08-614,706,503.87
期末现金及现金等价物余额61,284,963.03135,496,955.68106,326,377.1138,935,832.31
最新报告期:2024-04-26
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
开源证券余汝意0.620.891.322024-04-26
长江证券陈佳,徐晓欣,郭心驰0.690.871.082024-04-02
TOP↑